| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.033 | 0.9 |